Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody

摘要

#$%^&*AU2009210360B220110922.pdf#####Combination Treatment for Non-Hematologic Malignancies Using An Anti-IGF-1 R Antibody Abstract The present invention relates to a therapeutic method for the treatment of non5 hematologic malignancies comprising administering anti-IGF-IR antibodies, particularly human anti-IGF-lR antibodies, to a patient, in conjunction with the administration of at least one other therapeutic agent. The invention further relates to pharmaceutical compositions comprising these antibodies and methods of using such compositions thereof for treatment.